Skip to the content
Nice and Green - Leading Swiss Funding Firm
Contact
  • EN
  • DE
  • FR
  • Contact
  • About
  • Why us
  • Funding
  • Divestment
  • Code of Ethics
  • Careers
  • News
  • EN
  • DE
  • FR
– Latest news – Latest news
– Latest news – Latest news
  • All
  • Capital increase
  • Funding
  • Insight
Funding

05.05.2023

Nice & Green has signed an investment agreement with Facephi for up to 20M EUR through a Convertible Notes Funding Program…

Read more
Capital increase

02.03.2023

Nice & Green has contributed to the success of Affluent Medical’s capital increase, which raised over EUR 13,7 million

Read more
Capital increase

29.03.2023

Nice & Green has contributed as a guarantor in the capital increase of Global Bioenergies which raised over EUR 5.6 million…

Read more
Funding

15.02.2023

Nice & Green supports Amoéba with EUR 9 million in Straight Bond Funding Program…

Read more
Capital increase

31.01.2023

Nice & Green has contributed to the very successful capital increase of NFL Biosciences, a biopharmaceutical company that is developing botanical drugs for the treatment of addictions.

Read more
Next Page »

Stay connected.

Join us to stay up to date with the latest news.

Newsletter - EN
I accept the privacy policy *

Im Kontakt bleiben.

Bleiben Sie auf dem Laufenden.

Newsletter - DE
Ich akzeptiere die Datenschutzerklärung *

Être informé.

Recevoir notre actualité.

Newsletter - FR
J'accepte la politique de confidentialité *

Avenue Reverdil 12
1260 Nyon
Suisse

info@nicengreen.ch
LinkedIn

About
Why Us
Funding
Divestment

Geschäftsmodell
Wir über uns
Finanzierung
Beteiligungsverauserung

Activités
A propos
Financement
Cession de participations

Code of ethics
Careers
News
Legal

Ethik-Kodex
Karriere
News
Legal

Charte éthique
Carrières
News
Légal

© 2025 Nice and Green - Leading Swiss Funding Firm
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy